查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1833577

2032 年按钮式安全采血针市场预测：按规格尺寸、穿透深度、通路、应用、最终用户和地区进行的全球分析

Button-activated Safety Lancet Market Forecasts to 2032 - Global Analysis By Gauge Size (18G-21G (High Flow), 22G-25G (Moderate Flow), and 26G-30G (Low Flow)), Penetration Depth, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球按钮式安全采血针市场预计在 2025 年达到 7.7338 亿美元，到 2032 年将达到 19.2335 亿美元，预测期内的复合年增长率为 13.9%。

按钮式安全采血针是用于毛细血管采血的无菌设备，常用于血糖监测和诊断测试。它们在外壳内安装了一个隐藏式针头，只需按一下按钮即可释放。这种设计可以实现可控的快速穿刺，最大限度地减少不适感，同时防止针头意外暴露。使用后针头会自动缩回，确保采血过程中医护人员和病患的安全、感染控制和一次性使用的可靠性。

根据国际糖尿病联盟发布的数据，预计到2050年，非洲糖尿病患者数量将达到6,000万，与2024年该地区糖尿病盛行率相比增长约142%。

慢性病增多

糖尿病、心血管疾病和肾臟损害等慢性疾病负担日益加重，推动了对可靠血液采集设备（如按钮启动的安全采血针）的需求。这些设备提供了一种更安全、更有效的毛细血管采血方法，尤其适用于长期疾病监测。随着医疗保健系统向预防保健和早期诊断转变，采血针正成为常规检测通讯协定的重要组成部分。针头设计和减轻疼痛机制的技术进步正在提高患者的依从性。人口老化和新兴国家诊断意识的不断增强进一步扩大了用户群。个人化医疗和照护现场的兴起也在推动市场发展。

替代性非侵入性检测技术的兴起

穿戴式生物感测器和光学血糖监测仪等非侵入式诊断工具的出现，正在挑战传统的采血针针检测方法。这些替代技术提供无痛监测和持续数据追踪，吸引了精通技术、不愿使用针头的患者。经皮和唾液检测的创新正在获得发展动力，尤其是在居家照护和小儿科领域。随着数位健康平台整合这些技术，某些细分市场对采血针的依赖程度可能会降低。监管部门对非侵入式设备的支援正在加速其市场准入和普及。这种转变可能会限制按钮式安全采血针在先进医疗生态系统中的扩张。

与数位健康和​​远端医疗的整合

远端医疗和远端患者监护的兴起为按钮式安全采血针创造了新的机会。这些设备越来越多地与家庭诊断套件和连线健诊平台捆绑销售，以支援分散式护理。与行动应用程式和云端基础数据系统的集成，可以无缝追踪检测结果和患者依从性。新兴趋势包括蓝牙连接的智慧采血针和用于慢性病管理的自动记录功能。医疗保健提供者正在利用这些工具来增强虚拟会诊并减少就诊次数。随着数位生态系统的发展，安全采血针正成为远距离诊断工作流程的重要一环。

仿冒品品

不合格产品通常未经适当消毒，且不符合国际安全标准，导致感染风险增加和结果不准确。线上市场和分散的通路助长了假冒设备的氾滥。监管机构已加强监管和执法力度以遏制这一问题，但新兴市场仍有监管缺口。製造商正在投资防篡改包装和可追溯性技术，以保护产品的完整性。如果没有严格的品管，消费者信任和临床可靠性将面临风险。

COVID-19的影响：

新冠疫情加速了对安全易用的采血设备的需求，尤其是在居家医疗和隔离环境。按钮式安全采血针在隔离期间的大规模检测和慢性病监测中发挥了关键作用。虽然供应链中断最初阻碍了生产，但製造商透过自动化和本地筹资策略进行了调整。监管机构加快了家用设备的核准，扩大了市场进入。疫情过后，对感染控制和分散式照护的重视程度不断提高，使得采血针在医疗机构中继续广泛应用。

零售药局预计将成为预测期内最大的市场

由于零售药局的便利性和高客流量，预计在预测期内将占据最大的市场份额。药局是自检检测套组和慢性病监测工具的主要分销点。采血采血针製造商和连锁药局之间的策略联盟正在提高产品的知名度和可得性。药局营运的技术升级，例如数位库存和电子处方笺系统，正在简化采血针的销售。非处方诊断和健康计划的兴起进一步推动了需求。随着消费者健康意识的不断增强，零售药局仍然是采血针分销和教育的中心。

预计预测期内居家医疗领域将以最高的复合年增长率成长。

在以患者为中心的医疗服务转变的推动下，预计居家照护领域将在预测期内实现最高增长率。远端监控和自我检测的兴起使人们能够在家中管理慢性疾病。易于使用且能最大程度减轻疼痛的采血针在老年和儿科患者中越来越受欢迎。与远端医疗平台和行动医疗应用程式的整合正在提高家用采血针的效用。製造商正专注于人体工学设计和套件，以满足这一细分市场的需求。随着医疗保健的去中心化，家庭护理已成为安全采血针的关键成长领域。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额，这得益于医疗基础设施的不断扩张和诊断需求的不断增长。中国、印度和日本等国家正在投资公共卫生计画和慢性病筛检倡议。本地製造和优惠的政府政策正在推动采血针的产量和价格承受能力。该地区正在见证数位医疗工具和行动诊断工具的快速普及，从而推动采血针的普及。跨国公司与本地经销商之间的策略合作伙伴关係正在加速市场进入。亚太地区糖尿病人口众多且认知度不断提高，仍是市场规模的主要驱动力。

复合年增长率最高的地区：

在技​​术创新和强劲的医疗保健支出的推动下，北美地区预计将在预测期内呈现最高的复合年增长率。美国和加拿大在智慧采血针和整合诊断平台的开发方面处于领先地位。监管机构正在简化家用和连网型设备设备的核准途径，以促进更快的商业化。远端医疗和远端监控的广泛应用推动了对易于使用的采血针的需求。该地区也受益于强大的报销框架和消费者意识宣传活动。随着精准诊断的发展，北美将继续为采血针的创新和成长树立标竿。

免费客製化服务：

此报告的订阅者可以选择以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球按钮式安全采血针市场（依规格尺寸）

  • 18G至21G（高流量）
  • 22G至25G（中等流量）
  • 26G至30G（低流量）

6. 全球按钮启动安全采血针市场（按穿透深度）

  • 小于1.0毫米
  • 1.0～2.0mm

7. 全球按钮启动安全采血针市场（按通路）

  • 直销
  • 零售药局
  • 医疗用品经销商
  • 线上平台

8. 全球按钮启动安全采血针市场（按应用）

  • 血糖值检测
  • 新生儿足跟穿刺
  • 血红素检测
  • 胆固醇检测
  • 血液凝固检验
  • 其他用途

9. 全球按钮启动安全采血针市场（按最终用户）

  • 医院
  • 血库
  • 诊断实验室
  • 居家照护环境
  • 其他最终用户

第十章。全球按钮启动安全采血针市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Cardinal Health
  • Improve Medical
  • HTL-STREFA
  • Arkray Inc.
  • SARSTEDT AG & Co. KG
  • Lifescan Inc.
  • Terumo Corporation
  • Smiths Medical
  • Greiner Bio-One
  • Nipro Corporation
  • Medline Industries
  • Roche Diagnostics
  • Owen Mumford
  • Abbott Laboratories
  • Braun Melsungen AG
Product Code: SMRC31410

According to Stratistics MRC, the Global Button-activated Safety Lancet Market is accounted for $773.38 million in 2025 and is expected to reach $1923.35 million by 2032 growing at a CAGR of 13.9% during the forecast period. A button-activated safety lancet is a sterile device used for obtaining capillary blood, often in glucose monitoring and diagnostic tests. It incorporates a hidden needle secured inside a casing, released by a simple button press. This design provides controlled, rapid puncturing with minimal discomfort while preventing accidental needle exposure. The needle retracts automatically after use, ensuring safety, infection control, and single-use reliability for both medical staff and patients during blood sampling procedures.

According to data published by the International Diabetes Federation, the prevalence of diabetes is estimated to reach 60 million in Africa by 2050. This increase is around 142% as compared to the diabetes prevalence in the region in 2024.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The growing burden of chronic illnesses such as diabetes, cardiovascular conditions, and renal disorders is fueling demand for reliable blood sampling tools like button-activated safety lancets. These devices offer a safer and more efficient method for capillary blood collection, especially in long-term disease monitoring. As healthcare systems shift toward preventive care and early diagnosis, lancets are becoming integral to routine testing protocols. Technological advancements in needle design and pain-reduction mechanisms are improving patient compliance. Aging populations and increasing diagnostic awareness in emerging economies are further expanding the user base. The market is also benefiting from the rise of personalized medicine and point-of-care diagnostics.

Restraint:

Rise of alternative non-invasive testing technologies

The emergence of non-invasive diagnostic tools such as wearable biosensors and optical glucose monitors is challenging the growth of traditional lancet-based testing. These alternatives offer pain-free monitoring and continuous data tracking, appealing to tech-savvy and needle-averse patients. Innovations in transdermal and saliva-based testing are gaining traction, especially in homecare and pediatric settings. As digital health platforms integrate these technologies, the reliance on lancets may decline in certain segments. Regulatory support for non-invasive devices is accelerating their market entry and adoption. This shift could limit the expansion of button-activated safety lancets in advanced healthcare ecosystems.

Opportunity:

Integration with digital health and telemedicine

The growing adoption of telehealth and remote patient monitoring is creating new opportunities for button-activated safety lancets. These devices are increasingly bundled with home diagnostic kits and connected health platforms to support decentralized care. Integration with mobile apps and cloud-based data systems enables seamless tracking of test results and patient adherence. Emerging trends include smart lancets with Bluetooth connectivity and auto-logging features for chronic disease management. Healthcare providers are leveraging these tools to enhance virtual consultations and reduce hospital visits. As digital ecosystems evolve, safety lancets are becoming essential components of remote diagnostic workflows.

Threat:

Counterfeit products and substandard quality

Substandard products often lack proper sterilization and fail to meet international safety standards, leading to increased risk of infection and inaccurate results. Online marketplaces and fragmented distribution channels are contributing to the spread of unauthorized devices. Regulatory bodies are ramping up surveillance and enforcement to curb this issue, but gaps remain in emerging markets. Manufacturers are investing in tamper-proof packaging and traceability technologies to protect product integrity. Without stringent quality control, the market risks erosion of consumer trust and clinical reliability.

Covid-19 Impact:

The COVID-19 pandemic accelerated the demand for safe and easy-to-use blood sampling tools, especially in homecare and quarantine settings. Button-activated safety lancets played a crucial role in mass testing and monitoring of chronic conditions during lockdowns. Supply chain disruptions initially hampered production, but manufacturers adapted through automation and regional sourcing strategies. Regulatory agencies fast-tracked approvals for home-use devices, expanding market access. Post-pandemic, the emphasis on infection control and decentralized care continues to drive lancet adoption across healthcare settings.

The retail pharmacies segment is expected to be the largest during the forecast period

The retail pharmacies segment is expected to account for the largest market share during the forecast period, due to its accessibility and high consumer footfall. Pharmacies serve as key distribution points for self-testing kits and chronic disease monitoring tools. Strategic collaborations between lancet manufacturers and pharmacy chains are enhancing product visibility and availability. Technological upgrades in pharmacy operations, including digital inventory and e-prescription systems, are streamlining lancet sales. The rise of over-the-counter diagnostics and wellness programs is further boosting demand. As consumer health awareness grows, retail pharmacies remain central to lancet distribution and education.

The homecare settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate, driven by the shift toward patient-centric care. The rise of remote monitoring and self-testing is empowering individuals to manage chronic conditions from home. Lancets designed for ease of use and minimal pain are gaining popularity among elderly and pediatric users. Integration with telemedicine platforms and mobile health apps is enhancing the utility of home-use lancets. Manufacturers are focusing on ergonomic designs and bundled kits to cater to this segment. As healthcare decentralizes, homecare emerges as a vital growth frontier for safety lancets.

Region with largest share:

During the forecast period, the Asia Pacificregion is expected to hold the largest market share, supported by expanding healthcare infrastructure and rising diagnostic demand. Countries like China, India, and Japan are investing in public health programs and chronic disease screening initiatives. Local manufacturing and favorable government policies are boosting lancet production and affordability. The region is witnessing rapid adoption of digital health tools and mobile diagnostics, enhancing lancet penetration. Strategic alliances between global players and regional distributors are accelerating market access. With a large diabetic population and growing awareness, Asia Pacific remains a key driver of market volume.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by technological innovation and robust healthcare spending. The U.S. and Canada are leading in the development of smart lancets and integrated diagnostic platforms. Regulatory agencies are streamlining approval pathways for home-use and connected devices, encouraging rapid commercialization. High adoption of telehealth and remote monitoring is boosting demand for user-friendly lancets. The region also benefits from strong reimbursement frameworks and consumer awareness campaigns. As precision diagnostics evolve, North America continues to set the benchmark for lancet innovation and growth.

Key players in the market

Some of the key players in Button-activated Safety Lancet Market include Cardinal Health, Improve Medical, HTL-STREFA, Arkray Inc., SARSTEDT AG & Co. KG, Lifescan Inc., Terumo Corporation, Smiths Medical, Greiner Bio-One, Nipro Corporation, Medline Industries, Roche Diagnostics, Owen Mumford, Abbott Laboratories, and Braun Melsungen AG.

Key Developments:

In July2025, Cardinal Health announced the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio.

In September2021, LifeScanand Welldoc, a digital health leader revolutionizing chronic care, announced a strategic partnership to incorporate Welldoc's chronic condition platform, supporting hypertension, heart failure, diabetes, pre-diabetes and behavioral health, into the new OneTouch(R) Solutions portal, designed to offer a choice of support, guidance and digital tools to help people not just manage diabetes but thrive.

Gauge Sizes Covered:

  • 18G-21G (High Flow)
  • 22G-25G (Moderate Flow)
  • 26G-30G (Low Flow)

Penetration Depths Covered:

  • <1.0 mm
  • 1.0-2.0 mm

Distribution Channels Covered:

  • Direct Sales
  • Retail Pharmacies
  • Medical Supply Distributors
  • Online Platforms

Applications Covered:

  • Blood Glucose Testing
  • Neonatal Heel Stick
  • Hemoglobin Testing
  • Cholesterol Testing
  • Coagulation Testing
  • Other Applications

End Users Covered:

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Button-activated Safety Lancet Market, By Gauge Size

  • 5.1 Introduction
  • 5.2 18G-21G (High Flow)
  • 5.3 22G-25G (Moderate Flow)
  • 5.4 26G-30G (Low Flow)

6 Global Button-activated Safety Lancet Market, By Penetration Depth

  • 6.1 Introduction
  • 6.2 <1.0 mm
  • 6.3 1.0-2.0 mm

7 Global Button-activated Safety Lancet Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Retail Pharmacies
  • 7.4 Medical Supply Distributors
  • 7.5 Online Platforms

8 Global Button-activated Safety Lancet Market, By Application

  • 8.1 Introduction
  • 8.2 Blood Glucose Testing
  • 8.3 Neonatal Heel Stick
  • 8.4 Hemoglobin Testing
  • 8.5 Cholesterol Testing
  • 8.6 Coagulation Testing
  • 8.7 Other Applications

9 Global Button-activated Safety Lancet Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Blood Banks
  • 9.4 Diagnostic Laboratories
  • 9.5 Homecare Settings
  • 9.6 Other End Users

10 Global Button-activated Safety Lancet Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Cardinal Health
  • 12.2 Improve Medical
  • 12.3 HTL-STREFA
  • 12.4 Arkray Inc.
  • 12.5 SARSTEDT AG & Co. KG
  • 12.6 Lifescan Inc.
  • 12.7 Terumo Corporation
  • 12.8 Smiths Medical
  • 12.9 Greiner Bio-One
  • 12.10 Nipro Corporation
  • 12.11 Medline Industries
  • 12.12 Roche Diagnostics
  • 12.13 Owen Mumford
  • 12.14 Abbott Laboratories
  • 12.15 Braun Melsungen AG

List of Tables

  • Table 1 Global Button-activated Safety Lancet Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Button-activated Safety Lancet Market Outlook, By Gauge Size (2024-2032) ($MN)
  • Table 3 Global Button-activated Safety Lancet Market Outlook, By 18G-21G (High Flow) (2024-2032) ($MN)
  • Table 4 Global Button-activated Safety Lancet Market Outlook, By 22G-25G (Moderate Flow) (2024-2032) ($MN)
  • Table 5 Global Button-activated Safety Lancet Market Outlook, By 26G-30G (Low Flow) (2024-2032) ($MN)
  • Table 6 Global Button-activated Safety Lancet Market Outlook, By Penetration Depth (2024-2032) ($MN)
  • Table 7 Global Button-activated Safety Lancet Market Outlook, By <1.0 mm (2024-2032) ($MN)
  • Table 8 Global Button-activated Safety Lancet Market Outlook, By 1.0-2.0 mm (2024-2032) ($MN)
  • Table 9 Global Button-activated Safety Lancet Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 10 Global Button-activated Safety Lancet Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 11 Global Button-activated Safety Lancet Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 12 Global Button-activated Safety Lancet Market Outlook, By Medical Supply Distributors (2024-2032) ($MN)
  • Table 13 Global Button-activated Safety Lancet Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 14 Global Button-activated Safety Lancet Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Button-activated Safety Lancet Market Outlook, By Blood Glucose Testing (2024-2032) ($MN)
  • Table 16 Global Button-activated Safety Lancet Market Outlook, By Neonatal Heel Stick (2024-2032) ($MN)
  • Table 17 Global Button-activated Safety Lancet Market Outlook, By Hemoglobin Testing (2024-2032) ($MN)
  • Table 18 Global Button-activated Safety Lancet Market Outlook, By Cholesterol Testing (2024-2032) ($MN)
  • Table 19 Global Button-activated Safety Lancet Market Outlook, By Coagulation Testing (2024-2032) ($MN)
  • Table 20 Global Button-activated Safety Lancet Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Button-activated Safety Lancet Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Button-activated Safety Lancet Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Button-activated Safety Lancet Market Outlook, By Blood Banks (2024-2032) ($MN)
  • Table 24 Global Button-activated Safety Lancet Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 25 Global Button-activated Safety Lancet Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 26 Global Button-activated Safety Lancet Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.